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Abstract
The neurobiological activities of classical major histocompatibility class I (MHCI) molecules are just beginning to be
explored. To further examine MHCI’s actions during the formation of neuronal connections, we cultured embryonic mouse
retina explants a short distance from wildtype thalamic explants, or thalami from transgenic mice (termed ‘‘NSE-Db’’) whose
neurons express higher levels of MHCI. While retina neurites extended to form connections with wildtype thalami, we were
surprised to find that retina neurite outgrowth was very stunted in regions proximal to NSE-Db thalamic explants,
suggesting that a diffusible factor from these thalami inhibited retina neurite outgrowth. It has been long known that MHCI-
expressing cells release soluble forms of MHCI (sMHCI) due to the shedding of intact MHCI molecules, as well as the
alternative exon splicing of its heavy chain or the action proteases which cleave off it’s transmembrane anchor. We show
that the diffusible inhibitory factor from the NSE-Db thalami is sMHCI. We also show that COS cells programmed to express
murine MHCI release sMHCI that inhibits neurite outgrowth from nearby neurons in vitro. The neuroinhibitory effect of
sMHCI could be blocked by lowering cAMP levels, suggesting that the neuronal MHCI receptor’s signaling mechanism
involves a cyclic nucleotide-dependent pathway. Our results suggest that MHCI may not only have neurobiological activity
in its membrane-bound form, it may also influence local neurons as a soluble molecule. We discuss the involvement of
complement proteins in generating sMHCI and new theoretical models of MHCI’s biological activities in the nervous system.
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Introduction
Classical major histocompatability complex class I (MHCI) Ia
molecules play a central role in immune surveillance. The MHCI
complex is tripartite, consisting of a heavy chain (<44 kDa), b2
microglobulin (b2M) light chain (<12 kDa) and a short polypep-
tide of 8–10 amino acids from a cytosolic antigen that is bound to
a groove in the heavy chain [1,2]. By presenting peptides from
intracellular proteins on the cell surface, MHCI displays the
proteins that are being produced within the cell to the immune
system. MHCI on the cell surface is screened by CD82 T cells
using T cell receptors that were generated by gene rearrangement
to identify cells expressing foreign antigens. Additionally, the level
of MHCI expression on the cell surface is monitored by natural
killer (NK) cells using germ line encoded MHCI receptors in order
to identify cells that may be infected or transformed [2,3,4].
Although MHCI is well known as a membrane–bound molecule,
soluble forms of MHCI (sMHCI) also exist which were first
identified in the blood in the 1970’s ([5,6], reviewed in [7,8]).
sMHCI is generated by 1) the shedding of intact MHCI molecules
(which contain the full-length heavy chain with its transmembrane
segment and cytoplasmic tail [9,10]); 2) an alternative RNA splicing
pathway which deletes the heavy chain’s exon 5 which encodes its
transmembrane domain [11,12], and 3) by the action of intrace-
llular or extracellular proteases which cleave the heavy chain from
its transmembrane anchor [7,8,10]. However, sMHCI has no
known biological function under natural physiological conditions.
There is a growing recognition that molecules that have key roles
in immune surveillance also have important roles in neurodevelop-
ment. MHCI-deficient mice have an exuberance of retinal
projections in their thalamus and enhanced long term potentiation,
indicating that MHCI participates in activity-dependent synaptic
elimination [13]. Additionally, PirB, which is a MHCI receptor of
the innate immune system, is also a receptor for myelin inhibitors
and PirB-deficient mice have aberrations in cortical neuroplasticity
[14,15]. Mice lacking the proteins involved in the classical
complement cascade, C1q or C3, have deficiencies in CNS synapse
elimination that are similar to those of MHCI-deficient mice,
suggesting that MHCI-mediated synaptic elimination is dependent
in part on the action of complement proteins [16].
We have been interested in classical MHCI’s effects on wildtype
neurons. We observed that picomolar levels of recombinant
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soluble MHCI monomers could inhibit neurite outgrowth from
embryonic mouse retina explants in culture [17]. Interestingly,
neurons were more sensitive to growth inhibition by self-MHCI
than non-self MHCI monomers, regardless of the nature of the
peptide presented. Neurons from MHCI-deficient mice were
insensitive to growth inhibition by exogenous recombinant MHCI.
These findings suggest that endogenous expression of MHCI is
necessary to ‘‘educate’’ neurons to recognize self-MHCI, similar to
the educational process that NK cells undergo to express MHCI
receptors appropriate for the MHCI haplotype of the animal.
Recently, we studied transgenic C57Bl/6 mice (‘‘NSE-Db’’
mice) which have a neuron-specific enolase promoter driving the
expression of a full-length Db heavy chain (matching their
endogenous H-2D allele) specifically in their CNS neurons
[18,19]. These mice have elevated levels of functional Db on the
surface of their CNS neurons. We observed that enhanced
neuronal MHCI expression led to abnormalities in neurodevel-
opment, including a smaller retina projection area in their
thalamus, reduced synaptic makers and neurons in some regions
of their hippocampus and reduced axonal sprouting responses
after a hippocampal lesion [19]. Thus, elevated neuronal MHCI
expression can lead to alterations in CNS morphology, synaptic
connections and axon outgrowth.
In the current study, we wanted to further examine how ectopic
neuronal MHCI expression affects interactions between neurons in
vitro. As a model system, we used embryonic retina-thalamic
explant co-cultures. MHCI is expressed at low levels in embryonic
mouse thalami and its expression is greatly upregulated postnatally
during the period of activity-dependent remodeling [13]. Normal-
ly, when embryonic retina explants are cultured near to an
embryonic thalamus the retina ganglion cells (RGCs) extend axons
that form arbors and functional connections within the thalamic
explant [20,21]. We were surprised to find that retinas placed near
to a NSE-Db thalamic explant had very stunted neurite outgrowth
from the area proximal to the thalamic explant, suggesting that a
diffusible factor from the NSE-Db thalami inhibited retina neurite
outgrowth at a distance.
We surmised that the diffusible factor was sMHCI. In the
following studies, we demonstrate that conformationally correct
sMHCI is released from NSE-Db thalami, as well as COS cells
programmed to express a full-length Db heavy chain, leading to
inhibition of neurite outgrowth from nearby neurons. Our results
suggest that MHCI may not only have neurobiological activity as a
membrane-bound molecule, it may also affect local neurons as a
soluble molecule in vivo. We show that the neuroinhibitory activity
of sMHCI can be blocked by a cAMP antagonist, suggesting that
the neuronal MHCI receptor’s signaling mechanism involves a
cyclic nucleotide-dependent pathway. Finally, we discuss the role
of complement proteins in producing sMHCI and new models of
MHCI’s biological activities in the nervous system.
Materials and Methods
Animals
All studies were approved by the UCLA Chancellor’s Animal
Research Committee (approval #2000-023-33). C57Bl/6 mice
were purchased from The Jackson Laboratory (Bar Harbor,
Maine). The generation of C57BL/6 NSE-Db mice which express
elevated levels of Db on their neurons has been previously
described [18,19]. These transgenic mice have a neuron-specific
enolase (NSE) promoter driving the expression of a Db minigene
(containing all the Db coding region/exons) specifically in neurons,
resulting in higher levels of MHCI on the cell surface of CNS
neurons. The NSE-Db mice were backcrossed with C57BL/6 mice
for 10 generations and then bred them to homozygosity for the
transgene [19].
Retina-thalamic co-culture
Embryonic day 14 (E14) embryos from wildtype C57BL/6 or
transgenic C57Bl/6 NSE-Db mice were placed into petri dishes
containing Leibovitz’s L-15 media (Gibco BRL) and the retinas
and thalami were isolated. A retina was then placed <0.5 mm
from a wildtype, or a NSE-Db, thalamus in a matrigel matrix in an
8 chamber slide on ice. The slides were then incubated at 37uC for
30–60 minutes to solidify the gel. Neurobasal medium was added
to each chamber (0.2 ml) and the co-cultures were coded and
incubated for 4–5 days. The experiment was terminated by
replacing the media with 4% PFA and storing the slides at 4uC.
The co-cultures were scored in a subjective manner by two blinded
individuals for the relative extent of retinal neurite outgrowth
towards the thalamus (on a scale of 0–100). Only co-cultures with
a distance of 0.5–1.0 mm between the tissues were analyzed.
Duplicates of each group were tested simultaneously in at least 4
separate experiments. The scores of positive control cultures with
wildtype thalamus were normalized to represent 100% outgrowth
and all other group scores were adjusted accordingly.
Antibody neutralization of MHCI
All antibodies were coded and added to co-cultures of wildtype
retinas and NSE-Db thalami in a blinded fashion. Mouse anti-Db
mAb (HB-27, ATCC designation 28-14-8S), control isotype-
matched anti-Kk mAb (HB-16, ATCC designation 16-1-11N),
anti-GAD65 mAb (GAD-6, Sigma-Aldrich), or mouse IgG2a
(Sigma-Aldrich), all at 0.002 mg/ml, were added to the matrigel
(prior to its solidification) and to the media. All these antibodies are
the IgG2a isotype. Each experiment contained positive control co-
cultures of wildtype retinas confronted with wildtype thalami. The
co-cultures were incubated, fixed and scored in a blinded fashion,
as described above.
Retina explant cultures
E14 C57Bl/6 retinas were isolated and placed in matrigel as
described above. Thalami-conditioned media or recombinant
MHCI(1-298) (both described below) was then added to the
indicated concentration. Control cultures received the same
volume of conditioned media from wildtype thalami or COS cells
(American Type Culture Collection, Manassas, VA) transfected
with nonrecombinant plasmid. The cultures were coded and
incubated further at 37uC in 5% CO2 for <48 hours. The
experiment was terminated by replacing the media with 4% PFA
and storing the slides at 4uC. Images of retinal explant cultures
were imported into NIH Image Analysis software and analyzed for
area covered by the neurite projections. Statistical significance was
determined using a t-test or ANOVA.
Production of and testing of thalami conditioned media
Wildtype or NSE-Db thalami from 8–12 E14 fetuses were
cultured for 3–5 days in Neurobasal media with L-glutamine,
antibiotics and 1X B27 supplement. The conditioned media was
harvested and added to fresh wildtype retina explants at a 1:1
dilution with fresh media The cultures were incubated 2 days and
scored in a blinded fashion as described above.
COS cell aggregate and retina explants co-cultures
COS cells were transfected with a plasmid encoding the full-
length Db cDNA that contains MHCI’s transmembrane and
intracellular domain, or with a control plasmid (with an antisense
Shed MHC Molecules Modulate Neurite Outgrowth
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Db cDNA insert). COS cells were harvested 24 hours later and
aggregates were made by hanging 105 COS cells in a 20 ml drop
for 24 hours. An aggregate was then placed <0.5–1 mm from a
wildtype C57Bl/6 retina explant in a matrigel. After incubating
48 hours the cultures were fixed. In a blinded fashion, a
microscopic field of view was scored for the number of neurites
making contact with the COS cell pellet at multiple depths of
focus.
Production of sMHCI(1-298) from COS cells
A truncated MHCI-Db cDNA (containing exons 1–4 (amino
acids 1–298) plus a stop codon was subcloned into pIRES
(Invitrogen). Due to the lack of a transmembrane spanning region,
this MHCI molecule is secreted. COS cells were transfected
(LipofectAMINE 2000, Invitrogen) with the parental plasmid, or
the plasmid encoding sMHCI(1–298). The COS cell transfection
efficiencies with the parental plasmid and the sMHCI(1–298)
encoding plasmid were similar, as judged by the FACS analysis of
GFP expression (which is also expressed by the pIRES plasmid).
Forty eight hours later, the conditioned media was harvested and
added to fresh explant cultures at the concentration indicated.
Testing compounds that modulate cyclic nucleotide
levels
cAMP (20 mM) or Rp-cAMPS (R-diasteriomer of adenosine
39,59-cyclic-phosphorothioate) (20 mM) a non-hydrolyzable an-
tagonist of cAMP (Sigma-Aldrich) were added to the matrigel
(prior to solidification) and the media of the explant cultures at
the indicated concentrations. sMHC(1–298) was added to some
wells to a final concentration of 500 pM. Control cultures
received the same volume of conditioned media from nonrecom-
binant plasmid transfected COS cells. The cultures were coded
and incubated at 37uC in 5% CO2 for <48 hours and analyzed
in a blinded manner using NIH Image software for the area
covered by the neurite projections and the data analyzed using
t-test or ANOVA.
Results
Retina explant neurite outgrowth is stunted when in
proximity to thalami that express elevated levels of
neuronal MHCI
We cultured wildtype C57Bl/6 retina explants a short distance
from a wildtype C57Bl/6 or a NSE-Db mouse thalamic explant.
When juxtaposed with a wildtype thalamus explant, the retinas
extended axon projections in all directions, and formed contacts
with thalamic cells (representative image in Fig. 1A, group data in
Fig. 1C). In contrast, retinas cultured near to a NSE-Db thalamus
extended much shorter processes on the side nearest to the
thalamus (Figs. 1B, 1C). There was no reduction of the number of
neurites, or turning of the projections away from the Db thalamus
as occurs in the presence of a diffusible repulsive factor–rather,
neurite outgrowth was stunted on the side proximal to the NSE-Db
thalamus. These data suggest that NSE-Db thalami release a
diffusible factor(s) which can inhibit RGC neurite outgrowth at a
distance.
Figure 1.Retina explant neurite outgrowth in co-cultures with wildtype or NSE-Db thalami. Representative images of wildtype E14 retina
explant (labeled ‘‘R’’) neurite outgrowth when cultured near to a wildtype (A) or NSE-Db (B) E14 thalami (labeled ‘‘T’’). White scale bar = 100 microns.
(C) Group data of retinal neurite outgrowth toward a wildtype (wt) thalamus (open bar), or a NSE-Db thalamus (black bars), in the absence, or
presence, of different IgG2a antibodies. N = at least two co-cultures of each group were tested side-by-side in 4 separate experiments. **p,0.005,
***p,0.001 by Student’s t-test.
doi:10.1371/journal.pone.0018439.g001
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The neuroinhibitory factor from NSE-Db thalami is
soluble Db
Based on our previous finding that picomolar levels of
recombinant MHCI monomers (but not heavy chain or b2M
alone) inhibited RGC neurite outgrowth in vitro [17], we
hypothesized that the diffusible inhibitory factor from NSE-Db
thalami was sMHCI. In wildtype mice, neuronal MHCI
expression is induced postnatally in the thalamus during the
period of activity-dependent remodeling [13]. In NSE-Db mice
however, the NSE promoter drives the ectopic expression of the
Db heavy chain in the embryonic CNS as cells differentiate into
neurons. Previous studies of other tissues have found that
increased MHCI expression leads to a concomitant increase in
the release of sMHCI [22,23,24,25]. To test whether the diffusible
neuroinhibitory factor from NSE-Db thalamic tissue was soluble
Db MHCI, we added a conformation-dependent anti-Db mAb to
the co-cultures and observed that this rescued the ability of retinas
to extend processes towards a NSE-Db thalamus (Fig. 1C). In
contrast, addition of an isotype matched anti-Kk mAb, anti-
GAD65 mAb or mouse IgG2a to the cultures failed to rescue
neurite outgrowth toward the NSE-Db thalamus (Fig. 1C). These
data strongly suggest that the inhibitory factor from NSE-Db
thalami is conformationally correct sMHCI.
We also cultured embryonic wildtype C57Bl/6 or NSE-Db
thalami and harvested the conditioned media from each. We then
added the conditioned media to fresh retina explants in matrigel.
Neurite outgrowth from retinas grown with conditioned media
from wildtype thalamic cultures was similar to that from retinas
cultured in fresh media (Fig. 2). In contrast, conditioned media
from NSE-Db thalamic cultures inhibited neurite outgrowth
(Fig. 2). Addition of the conformation-dependent anti-Db-specific
mAb, but not an anti-Kk mAb, to the conditioned media from
NSE-Db thalamic cultures significantly reduced its inhibitory
activity (Fig. 2). These studies further indicate NSE-Db thalami
release sMHCI which can affect neurite outgrowth from other
neurons.
Aggregates of Db-expressing COS cells inhibit neurite
outgrowth from nearby neurons
To further test the notion that MHCI-expressing cells can
release sMHCI which can affect nearby neurons, we transfected
monkey COS cells with a plasmid encoding a full-length Db
cDNA, or a control plasmid containing the Db cDNA in the anti-
sense orientation. The presence of membrane-bound Db on the
surface of experimental, but not control, transfected COS cells was
confirmed by staining with anti-Db mAb and FACS analysis (data
not shown). The transfected cells were cultured using the hanging
drop method to obtain an aggregate and the aggregate was placed
<0.5–1 mm from a fresh E14 wildtype retina explant. Retinas
that were cultured near to an aggregate of control COS cells sent
out projections in all directions, some of which made contact with
the COS cell aggregate (Fig. 3A). Retinas cultured near to a Db-
expressing COS cell aggregate sent out a similar number of
neurites, but few neurites made contact with the aggregate (Fig. 3B,
3C). The retina projections did not turn away from the aggregate,
but rather had limited outgrowth from the region proximal to Db-
expressing COS cells. Thus, COS cells that differ only in their
expression of Db-MHCI have very different affects on neurite
outgrowth from nearby neurons.
Picomolar levels of sMHCI(1-298) from transfected COS
cells inhibit retinal neurite outgrowth
We engineered COS cells to produce sMHCI by transfecting
them with a plasmid which directs the expression of a slightly
truncated Db (amino acids 1–298) which lacks its COOH-terminal
membrane anchor, which we will refer to as sMHCI(1–298). We
verified the presence of soluble Db MHCI in the media from
transfected COS cells by adding 35S methionine to some cultures
and immunoprecipitating radiolabeled proteins in the culture
supernatants with a conformation-dependent anti-Db mAb
followed by SDS-PAGE analysis (Fig. 4A). We detected Db
complexed with b2M in the conditioned media of COS cells
transfected with the plasmid encoding Db, but not in those
transfected with the control plasmid (Fig. 4A). The association of
mouse Db heavy chain with monkey b2M is expected since mouse
heavy chains bind with greater affinity to human b2M than to
mouse b2M, conferring greater stability to the complex [26].
ELISA analysis of conditioned media from unlabeled transfected
COS cells indicated that Db sMHCI(1–298) was present in the
media at < 1.0 nM. We measured retina explant neurite
outgrowth in the presence of a dose range of sMHC(1–298) from
transfected COS cells. We observed that the extent of inhibition by
sMHCI(1–298) was concentration-dependent (Fig. 4B). Represen-
tative images of cultured retina explants are shown in Fig. 4C and
4D. The inhibitory effect of sMHCI(1–298) was detectable at
<50–100 pM (Fig. 4B), a dose similar to that at which recom-
binant self-MHCI monomers began to have a discernable effect
[17]. In a parallel study, we tested conditioned media from COS
cells that express a truncated Dd heavy chain and observed that
this had similar neuroinhibitory activity on retina explants from
Balb/C (H-2d) mice (Fig. S1). Since the sMHCI(1–298) produced
by COS cells are loaded with peptides from monkey cell proteins,
and has similar effects as self-MHCI monomers, these observations
provide further evidence that retina neuron MHCI receptors are
not specific for the peptide presented by MHCI. The inhibitory
effects of conditioned media from Db sMHCI(1–298)-expressing
Figure 2. NSE-Db thalami-conditioned media inhibits retina
neurite outgrowth. Wildtype (wt) or NSE-Db E14 thalamic explants
were cultured and the conditioned media (cm) harvested. E14 retina
explants were grown in fresh media (open bar), or a 1:1 mixture of fresh
media and cm from wt (hatched bar) or NSE-Db (‘‘NSE’’, black bars)
thalami, in the presence or absence of the indicated mAb, and the
extent of neurite outgrowth assessed. N = at least two co-cultures of
each group were tested side-by-side in 4 separate experiments. Data
shown are the mean relative outgrowth6 SEM. **p,0.005 by Student’s
t-test.
doi:10.1371/journal.pone.0018439.g002
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COS cells could be largely prevented by subtracting the
conditioned media with a conformation-dependent anti-Db
mAb, but not with an isotype matched MHCI-Kk specific mAb
(4E), confirming that the neuroinhibitory effect was mediated by
Db sMHCI(1–298).
A protein kinase A (PKA) antagonist neutralizes the
neuroinhibitory effects of rMHCI
The adenylate cyclase-cAMP-protein kinase A pathway conveys
an ‘off’ signal to both T cell and NK cell responses [27,28]. We
hypothesized that the inhibitory effects of sMHCI on neuronal
outgrowth may also involve this signaling pathway. We therefore
determined the effect of compounds that inhibit, or activate, a
cyclic nucleotide-dependent pathway on neurite outgrowth from
retina explants in the presence, or absence, of sMHCI(1–298).
Retinas cultured in the presence of COS cell-produced
sMHCI(1–298) (but no drug), had significantly less neurite
extension compared to cultures without sMHCI(1–298) (Fig. 5).
Neurite outgrowth from retinas cultured in the presence of Rp-
cAMPS, a PKA inhibitor was similar to that of control retinas
grown in media alone. Addition of Rp-cAMPS to retina explant
cultures containing sMHCI(1–298) almost completely prevented
the inhibitory effects of sMHCI(1–298) (Fig. 5), suggesting that
part of the signaling cascade behind the inhibitory action of
MHCI involves a cyclic nucleotide-dependent pathway. Retinas
grown in the presence of cAMP had on average greater neurite
outgrowth, as has been previously observed [29], but this was not
statistically significant in our culture system. Addition of cAMP to
retina cultures only partially prevented the inhibitory effects of
sMHCI(1–298); the average neurite outgrowth in the presence of
sMHCI(1–298) was significantly greater in the presence of cAMP,
but this was still significantly less than that in cultures without
sMHCI(1–298) (Fig. 5). These data suggest that the inhibitory
effect of sMHCI is highly dependent on PKA and that this
inhibition can be partially down-regulated by exogenous cAMP.
Discussion
The elevated neuronal MHCI expression in NSE-Db mice is
associated with lower levels of synaptic markers and fewer neurons
in some regions of their hippocampus, as well as a smaller area of
contralateral retina projections in their dLGN [19]. The current
studies were aimed at further understanding how elevated
neuronal MHCI levels affect neuronal connections using an
in vitro embryonic retina-thalamic co-culture system. In wildtype
thalami, MHCI expression is up-regulated postnatally and is
activity-dependent [13]. We observed that embryonic retina
explants that were cultured near to a embryonic wildtype thalamus
extended neurites which formed connections the thalami, as
expected. In contrast, there was a conspicuous lack of neurite
outgrowth from retina explant regions that were proximal to
thalamic explants from NSE-Db mice, suggesting that this
thalamic tissue released a factor that inhibited nearby neurite
outgrowth. Since our previous studies showed that recombinant
MHCI monomers (but not heavy chain alone or b2M alone)
inhibited neurite outgrowth in vitro [17], we surmised that the
NSE-Db thalami were producing sMHCI which inhibited neurite
outgrowth from neighboring neurons. Indeed, in other tissues,
upregulated MHCI expression leads to increased release of
sMHCI [22,23,24,25]. However, it was also possible that the
Figure 3. Aggregates of Db-expressing COS cells inhibit neurite
outgrowth from nearby retinal explants. Representative images
of neurite outgrowth from retina explant (labeled ‘‘R’’) cultured near
to an aggregate of control COS cells that were transfected with a
plasmid which contains the Db cDNA in an antisense orientation (A),
or express a full length Db cDNA and have conformationally correct
Db MHCI on their cell surface (B) (as demonstrated by FACS, data
not shown). C) Graph of the average number of retina neurites
contacting control or Db-expressing COS cell aggregate +/2
SEM. N= 11–15 wells from 2 independent experiments. P # 0.001
by Student’s t test.
doi:10.1371/journal.pone.0018439.g003
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Figure 4. Recombinant, soluble MHCI [sMHCI(1-298)] inhibits retina neurite outgrowth. A) COS cells were transfected with a non-
recombinant plasmid (lane 1) or one encoding Db heavy chain amino acids 1–298 which lacks a membrane anchor (lanes 2 and 3), and grown for
48 hrs in 35S methionine containing media. The media was harvested, a conformation-dependent anti-MHCI-Db (lanes 1 and 3) or anti-MHCI-Kk (lane
Shed MHC Molecules Modulate Neurite Outgrowth
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transgene in some way reduced thalamic secretion of neurotrophic
factors or induced the expression of a soluble inhibitory factor(s)
other than sMHCI. We observed that neurite outgrowth could be
rescued in large part by adding a conformation-dependent anti-Db
mAb to these cultures, pointing to diffusible conformationally
correct Db sMHCI as the inhibitory factor released from NSE-Db
thalami.
We also examined how retina neurites interacted with monkey
COS cells that were programmed to express a full-length Db
cDNA. FACS analysis with a conformation-dependent mAb
confirmed the presence of Db-MHCI on their cell surface. While
retina neurites made contacts with a nearby COS cell aggregates
transfected with a control plasmid, they had little neurite
outgrowth from regions near to Db-expressing COS cell
aggregates and made few contacts with these cells. These studies
show that transfected cells that differ in their expression of a full-
length mouse MHCI heavy chain cDNA differentially affect
neurite outgrowth from nearby neurons.
Our studies with COS cell-produced sMHCI(1–298) showed that
sMHCI(1–298) inhibited neurite outgrowth at 50–100 pM, a level
similar to that of recombinant Db-MHCI monomers loaded with a
particular mouse self-peptide [17]. The Db-sMHCI released from
the transfected COS cells present a vast array of different peptides
from monkey cell proteins. This provides another line of evidence
indicating that RGC MHCI receptors are not sensitive to the
peptide presented by MHCI. Because of this lack of specificity for
the peptide presented, any conformationally correct sMHCI is a
potential ligand, which may be why neurons are sensitive to such
low levels of sMHCI. Notably, little or no sMHCI is detected in CSF
of healthy individuals [30] indicating that the blood brain barrier
effectively blocks sMHCI in peripheral blood from entering the
CNS. Consequently, the level of MHCI expression in a particular
brain region may be the major regulator of local sMHCI levels.
In the immune system, T cells that engage soluble MHCI, or
membrane-bound MHCI without sufficient co-stimulatory signals,
enter a state of inactivity (anergy) or can apoptose [31,32,33]. T cell
inactivation by MHCI can be prevented by blocking the T cell
receptor’s signaling cascade with an antagonist (Rp-cAMPS) of
cAMP-dependent PKA [28,34]. Similarly, sMHCI down-regulates
NK cell function or induces NK cell apoptosis [35,36], and
compounds that elevate cAMP suppress both NK and dendritic cell
function [37]. We found that Rp-cAMPS itself had no discernable
effect on retinal neurite outgrowth in vitro. However, its inclusion in
cultures containing sMHCI(1–298) prevented the inhibitory effects of
sMHCI(1–298) on neurite outgrowth. Evidently, sMHCI can inhibit
cellular functions by pathways that involve PKA in both the nervous
and immune systems. Conceivably, the neuroinhibitory activity of
sMHCI that we have observed may be a neurological counterpart of
its inhibitory action on NK cells or T cells that engage sMHCI or
membrane-bound MHCI in the absence of co-stimulatory signals.
Our observations concerning sMHCI, together with the abnormal-
ities observed in NSE-Db mouse neurodevelopment [19], suggest
several new possibilities concerning MHCI’s neurobiological activities.
NeuronalMHCI expression in the thalamus peaks during the period of
activity-dependent remodeling [13]. Studies with other tissues have
shown that increased MHCI expression is accompanied by increased
release of sMHCI [22,23,24,25]. This could be due to increased
shedding of intact MHCI, increased heavy chain transcription leading
a concomitant increase in alternatively spliced transcripts and/or more
substrate for the action of proteases. After appropriate connections are
formed, elevated membrane-bound MHCI and sMHCI levels may
help limit axon outgrowth into that region and additional synapto-
genesis. Indeed, we have observed that the NSE-Dbmice have reduced
synaptic markers in some hippocampal regions and are very deficient
in compensatory neuronal sprouting responses after a hippocampal
lesion [19]. The sMHCI might bind to neuronal MHCI receptors in
ways that activate receptor signaling, or conversely, prevent theMHCI
receptor from binding to membrane-bound MHCI. Additionally,
MHCI receptor interaction with sMHCI without the co-stimulatory
signals that accompany MHCI receptor interaction with membrane-
boundMHCI,may lead to different biological outcomes. Alternatively,
like some other axon guidance molecules, MHCI and sMHCI may
have bi-functional effects, exerting either negative or positive influences
Figure 5. Modulation of intracellular cAMP levels affects
sMHCI(1-298)-mediated inhibition of neurite outgrowth. Data
shown are the average area of retina neurite outgrowth +/2 SEM in the
presence of media alone (control), sMHCI(1–298) (500 pM), the cAMP
antagonist, Rp-cAMPS (20 mM), cAMP (20 mM), sMHCI(1–298)+Rp-
cAMPS and sMHCI(1–298)+cAMP. There was a statistically significant
difference across groups by ANOVA (p,0.001). N = 11–31 wells from
2–6 experiments. Statistical analyses were measured using ANOVA
with post-hoc Tukey-Kramer multiple comparisons test. *p,0.05,
***p,0.001.
doi:10.1371/journal.pone.0018439.g005
2) mAb was added, the bound proteins were collected on protein A sepharose beads and analyzed using SDS-PAGE and autoradiography. Image
shows labeled immunoprecipitated proteins with the expected molecular weights of the Db heavy chain and b2m in lane 3. B) Retina neurite
outgrowth in the presence of a dose range of sMHCI(1–298). N = 8 wells from 2 experiments. There was a significant main effect of dilution
concentration on average neurite outgrowth (F(4,34) = 9.54; p,0.001). This was further confirmed by the systematic increase of neurite outgrowth with
subsequent reductions in dilution concentration (R2 = 0.3215; F(1,37) = 17.53; p,0.001). Representative composite images of an retina explant cultured
with (C) conditioned media from control COS cell cultures, or (D) conditioned media from sMHCI(1–298) expressing COS cells (image shown is from a
culture with 500 pM sMHCI(1–298)). Composite photos are shown at the same magnification. E) Average neurite outgrowth from retina explants
grown in media alone (open bar), media to which conditioned media from COS cells transfected with a control plasmid (hatched bar), or a plasmid
encoding Db(1–298) (black bars) was added. The indicated mAb was added to some cultures. N = 23–27 wells from 4 experiments. **p,0.01,
***p,0.002 by Student’s t-test.
doi:10.1371/journal.pone.0018439.g004
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on axon growth depending on the context (e.g., their concentration,
the levels of cyclic nucleotides, and the stage in development)
[38,39,40,41,42].
Interestingly, mice deficient in complement protein C1q or C3 have
impairments in retinogeniculate synapse elimination, similar to that
seen in MHCI-deficient mice [16], suggesting that complement acts to
tag supernumerary synapses for removal by phagocytotic mechanisms.
Complement proteins can be synthesized by neurons and glia and their
expression peaks during activity dependent remodeling [16]. C1q
combines with serine esterases C1r and C1s to form the C1 protein.
Notably, C1 can associate with b2M and its serine esterase activity can
cleave MHCI between its a2 and a3 domains, releasing a biologically
active sMHCI consisting of the a1 and a2 domains associated with
b2M [43,44,45,46,47]. C3 also contributes to the formation of
proteases. Both C1q expression and neuronal MHCI expression peak
in the LGN during activity-dependent remodeling [13,16]. The
concurrent upregulation of both MHCI and complement protein
expression could synergistically elevate sMHCI levels in the microen-
vironment which we have shown can act in trans to inhibit neurite
outgrowth ([17,48] and herein). Such complement cleavage would also
reduce MHCI cis-associations with other molecules on the same cell
surface. Additionally, MHCI molecules can dissociate, leaving free
heavy chains on the cell surface which can associate in cis with other
free heavy chains and receptors on the same cell surface and modulate
cellular functions (reviewed in [49]). Complement cleavage of free
heavy chains could reduce these cis-associations as well. Importantly,
our recent studies suggest that the extent of MHCI cis interactions on
the neuronal cell surface modulate axon outgrowth and polarity (Tina
Bilousova and DLK, manuscript in preparation). Cleavage also leaves
behind MHCI’s a3 domain which can interact with some classical
MHCI receptors of the innate immune system [50,51,52]. Further
studies are needed to address these possibilities, but are hampered by
the lack of nucleic acid probes and antibodies that can distinguish
sMHCI and membrane-bound MHCI in tissue sections.
Neuronal MHCI and complement protein expression are
upregulated in response to various insults (e.g. seizures, injury,
cytokines and other inflammatory signals) [16,53,54,55,56,
57,58,59,60,61]. Our results in the current study, together with
our previous observations of abnormalities in neuronal connec-
tions and neurorepair responses in the NSE-Db mouse CNS
suggest that such insults may increase local levels of MHCI and
sMHCI which could affect neurodevelopment and neurorepair
responses. It is of interest that the HLA region has been genetically
associated with schizophrenia and autism in humans [62,63]. If
MHCI and/or sMHCI are found to have potential deleterious
neurological effects, MHCI antibodies, soluble MHCI receptors or
anti-inflammatory medications may useful to block these effects.
Supporting Information
Fig. S1 Data shows average neurite outgrowth from E14
Balb/C retina explants grown in media to which
conditioned media from COS cells transfected with a
control plasmid (hatched bar) or a plasmid encoding a
truncated Dd heavy chain (black bar) was added. N=at
least 21 wells from 3 experiments. **p,0.001 by Student’s t-test.
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